Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	0.84	-82.04	-82.73
Graham Fair Price	41.56	3.63	2.56
PEG	-48.97	0.18	-0.34
Price/Book	10.83	0.31	0.28
Price/Cash Flow	-36.96	9.23	-14.65
Prices/Earnings	-44.59	17.53	31.64
Price/Sales	-48.03	2.27	4.36
Price/FCF	-36.96	9.23	-14.65
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1.65	0.98	1.00
Operating Margin	-53.10	0.05	0.10
ROA	118.24	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	45.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.14	< 0.005	-99.29
EBIT QOQ	-0.61	0.00	inf
EPS QOQ	-0.92	1.00	8.59
FCF QOQ	-1.70	2.76	62.22
Revenue QOQ	-0.52	1.13	119.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	< 0.005	100.00
Quick Ratio	2.29	6.47	182.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	11.56	11.57	0.10
Cash	1.22	3.81	213.65
Capex	< 0.005	-0.01	-100.20
Free Cash Flow	-0.22	0.38	75.98
Revenue	0.73	1.57	113.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.29	6.93	202.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	50.69	65.83	29.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating